These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. López-Guillermo A; Cid J; Salar A; López A; Montalbán C; Castrillo JM; González M; Ribera JM; Brunet S; García-Conde J; Fernández de Sevilla A; Bosch F; Montserrat E Ann Oncol; 1998 Aug; 9(8):849-55. PubMed ID: 9789607 [TBL] [Abstract][Full Text] [Related]
6. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression. Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry. Pedersen MB; Hamilton-Dutoit SJ; Bendix K; Møller MB; Nørgaard P; Johansen P; Ralfkiaer E; Brown Pde N; Hansen PB; Jensen BA; Madsen J; Schöllkopf C; d'Amore F Hematol Oncol; 2015 Dec; 33(4):120-8. PubMed ID: 25052551 [TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi. Morabito F; Gallamini A; Stelitano C; Callea V; Guglielmi C; Neri S; Lazzaro A; Orsucci L; Ilariucci F; Sacchi S; Vitolo U; Federico M Cancer; 2004 Oct; 101(7):1601-8. PubMed ID: 15378507 [TBL] [Abstract][Full Text] [Related]
9. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience. Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536 [TBL] [Abstract][Full Text] [Related]
10. Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry. Ellin F; Landström J; Jerkeman M; Relander T Blood; 2014 Sep; 124(10):1570-7. PubMed ID: 25006130 [TBL] [Abstract][Full Text] [Related]
11. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma. Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138 [TBL] [Abstract][Full Text] [Related]
13. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma. Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis. Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433 [TBL] [Abstract][Full Text] [Related]
15. Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience. Han X; Zhang W; Zhou D; Ruan J; Duan M; Zhu T; Li J; Cai H; Cao X; Ouyang M J Int Med Res; 2017 Feb; 45(1):290-302. PubMed ID: 28222648 [TBL] [Abstract][Full Text] [Related]
16. The aggressive peripheral T-cell lymphomas: 2015. Armitage JO Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230 [TBL] [Abstract][Full Text] [Related]
17. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas]. Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549 [TBL] [Abstract][Full Text] [Related]
18. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL). Cottereau AS; Becker S; Broussais F; Casasnovas O; Kanoun S; Roques M; Charrier N; Bertrand S; Delarue R; Bonnet C; Hustinx R; Gaulard P; de Leval L; Vera P; Itti E; Mounier N; Haioun C; Tilly H; Meignan M Ann Oncol; 2016 Apr; 27(4):719-24. PubMed ID: 26787236 [TBL] [Abstract][Full Text] [Related]
20. Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL). Janikova A; Michalka J; Chloupkova R; Kopalova N; Campr V; Kamaradova K; Kren L; Belada D; Benesova K; Dlouha J; Klener P; Procházka V; Mocikova H; Duras J; Trneny M Ann Hematol; 2022 Apr; 101(4):789-798. PubMed ID: 35061088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]